In an ICC dispute, CRA was retained by respondent regarding the renegotiation of price in a supply agreement for a pharmaceutical sold in Japan. In expert reports and testimony, CRA evaluated the adequacy of returns made by respondent with request to development and commercialization of the product for the Japanese market.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...